Primary Hyperparathyroidism: Modern Conception and Clinical Observation

The article is devoted to one of the actual medical and social problems — primary hyperparathyroidism, the late diagnosis of which leads to the development of severe complications and an increased risk of premature death. Unlike developed countries, where 80% of cases are represented by mild forms of the disease, in the Russian Federation this indicator does not exceed 30%, while 70% are manifest forms. Widespread awareness of doctors of various specialties in the diagnosis of parathyroid adenoma is necessary for the timely detection of the disease. The article reflects the main stages of the study of the disease, the pathogenesis of the clinical manifestations of primary hyperparathyroidism, the classic symptoms of which are changes in the target organs of the parathyroid hormone — bone tissue, urinary system and gastrointestinal tract, is considered. Bone disorders are the most common manifestation of hyperparathyroidism and are characterized by increased bone metabolism with a progressive decrease in bone mineral density. Typical changes in the kidneys include nephrolithiasis and nephrocalcinosis, causing the formation of renal failure. Gastrointestinal signs of hyperparathyroidism are erosion and ulcers of the stomach and duodenum, prone to bleeding, recurrent pancreatitis. Diagnosis of the disease is based on laboratory results, characterized by elevated levels of calcium and parathyroid hormone in the blood. Visualization of the paradenomas in most cases is provided by ultrasound and scintigraphy. Removal of parathyroid adenoma is the most effective treatment. A clinical case of a severe form of the disease is presented, indicating an urgent need to take measures to solve the problem of primary hyperparathyroidism.

1. Mokrysheva N.G., Eremkina A.K., Slashchuk K.Yu. et al. Atypical parathyroid adenoma with a clinically aggressive course of primary hyperparathyroidism: an observation from practice. Endocrine surgery. 2018; 12 (1): 55–63. doi: 10.14341/serg9587 [In Russian].

2. Makarov I.V., Galkin R.A., Prokofiev N.A. et al. Experience in the diagnosis and surgical treatment of primary hyperparathyroidism. Endocrine surgery. 2017; 11 (2): 81–89. doi: 10.14341/serg2017281-89 [In Russian].

3. Rikhsieva N.T. Primary hyperparathyroidism: etiology, pathogenesis, clinical features, diagnosis, treatment, quality of life (literature review). International Endocrinology Journal. 2014; 1 (57): 103–108 [In Russian].

4. Yanevskaya L.G., Karonova T.L., Sleptsov I.V. Primary hyperparathyroidism: clinical forms and their features. Results from a retrospective study. Clinical and experimental thyodology. 2019; 15 (1): 19–29 [In Russian].

5. Farkhutdinova L.M. Primary hyperparathyroidism: ways to solve the problem. Bulletin of the Academy of Sciences of the Republic of Bashkortostan. 2010.15 (1): 22–27 [In Russian].

6. Usta A., Alhan E., Cinel A. et al. A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg. 2015; 100 (4): 648–655.

7. Borodin A.V., Isakova E.V., Kotov S.V. Polyneuromyopathy in primary hyperparathyroidism. Journal of Neurology and Psychiatry. 2012; 2: 52–56. [in Russian] Borodin A.V., Isakova E.V., Kotov S.V. Polyneuromyopathy in primary hyperparathyroidism. Journal of Neurology and Psychiatry. 2012; 2: 52–56 [In Russian].

8. Kalinin A.P., Kotova I.V., Britvin T.A. and others. Hypercalcemic crisis. Almanac of clinical medicine. 2014; 32: 101–104 [In Russian].

9. Cipriany C., Biamonte F., Costa A.G. et al. Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology. J Clin Endocrinol Metab. 2015; 100: 139–15.

10. Berger C., Almohareb O., Langsetmo L. et al. Characteristics of hyperparathyroid states in the Canadian multicenter osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol (Oxf). 2015; 82: 359–68.

11. Clinical recommendations. Primary hyperparathyroidism. 2019. [Electronic resource]. URL: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/kr_pgpt_09.12.2019.pdf. (date of the application: 21.12.2019) [In Russian]

12. Chernyshev V.A., Khamidullin R.G., Rudyk M.A., Busygin A.L. Tumors of the parathyroid glands in an oncology clinic. Volga Oncology Bulletin. 2017; 4 (31): 67–77 [In Russian].

13. Khan A.A., Hanley D.A., Rizzoli R. et al. Primary hyperparathyroidism review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017; 28: 1–19. doi: 10.1007/s00198-016-3716-2

14. Denizot A., Grino M., Oliver C. Surgical management of primary hyperparathyroidism. J Am Geriatr Soc. 2014; 62: 1759–63.

15. Lundstam K., Heck A., Mollerap C. et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2015; 100: 1359–67.

16. Marcocci C., Bollerslev J., Khan A.A., Shoback D.M. Medical management of primary hyperparathyroidism: proceeding of the fourth International Workship of the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2014; 99: 3607–18.

17. Tassone F., Guarniery A., Castellano E. et al. Parathyroidectomy halts the deterioration of renal function in primary hyperparathyroidism. J Clin Endocrinol Metab. 2015; 100: 2069–73.